Mirrx Therapeutics

Developer of microRNA-blocking oligonucleotides for cancer, cardiovascular, immunological and viral diseases

placeLyngby, Capital Region Of Denmark, Denmark calendar_todayFounded 2009 groups11 employees language mirrx.com
Coming soon